Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
The global Androstenedione market was valued at US$ 199.9 million in 2023 and is anticipated to reach US$ 243.3 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.
China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.
This report aims to provide a comprehensive presentation of the global market for Androstenedione, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androstenedione.
Report Scope
The Androstenedione market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androstenedione market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androstenedione manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
Consumption by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Androstenedione manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Androstenedione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Androstenedione Market Overview
1.1 Product Overview and Scope of Androstenedione
1.2 Androstenedione Segment by Type
1.2.1 Global Androstenedione Market Value Comparison by Type (2024-2030)
1.2.2 Androstenedione
1.2.3 Androstadienedione
1.3 Androstenedione Segment by Application
1.3.1 Global Androstenedione Market Value by Application: (2024-2030)
1.3.2 Arthritis Pharmaceuticals
1.3.3 Fertility Control Pharmaceuticals
1.3.4 Infectious Inflammation Pharmaceuticals
1.3.5 Others
1.4 Global Androstenedione Market Size Estimates and Forecasts
1.4.1 Global Androstenedione Revenue 2019-2030
1.4.2 Global Androstenedione Sales 2019-2030
1.4.3 Global Androstenedione Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Androstenedione Market Competition by Manufacturers
2.1 Global Androstenedione Sales Market Share by Manufacturers (2019-2024)
2.2 Global Androstenedione Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Androstenedione Average Price by Manufacturers (2019-2024)
2.4 Global Androstenedione Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Androstenedione, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Androstenedione, Product Type & Application
2.7 Androstenedione Market Competitive Situation and Trends
2.7.1 Androstenedione Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Androstenedione Players Market Share by Revenue
2.7.3 Global Androstenedione Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Androstenedione Retrospective Market Scenario by Region
3.1 Global Androstenedione Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Androstenedione Global Androstenedione Sales by Region: 2019-2030
3.2.1 Global Androstenedione Sales by Region: 2019-2024
3.2.2 Global Androstenedione Sales by Region: 2025-2030
3.3 Global Androstenedione Global Androstenedione Revenue by Region: 2019-2030
3.3.1 Global Androstenedione Revenue by Region: 2019-2024
3.3.2 Global Androstenedione Revenue by Region: 2025-2030
3.4 North America Androstenedione Market Facts & Figures by Country
3.4.1 North America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Androstenedione Sales by Country (2019-2030)
3.4.3 North America Androstenedione Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Androstenedione Market Facts & Figures by Country
3.5.1 Europe Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Androstenedione Sales by Country (2019-2030)
3.5.3 Europe Androstenedione Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androstenedione Market Facts & Figures by Country
3.6.1 Asia Pacific Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Androstenedione Sales by Country (2019-2030)
3.6.3 Asia Pacific Androstenedione Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Androstenedione Market Facts & Figures by Country
3.7.1 Latin America Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Androstenedione Sales by Country (2019-2030)
3.7.3 Latin America Androstenedione Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Androstenedione Market Facts & Figures by Country
3.8.1 Middle East and Africa Androstenedione Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Androstenedione Sales by Country (2019-2030)
3.8.3 Middle East and Africa Androstenedione Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Androstenedione Sales by Type (2019-2030)
4.1.1 Global Androstenedione Sales by Type (2019-2024)
4.1.2 Global Androstenedione Sales by Type (2025-2030)
4.1.3 Global Androstenedione Sales Market Share by Type (2019-2030)
4.2 Global Androstenedione Revenue by Type (2019-2030)
4.2.1 Global Androstenedione Revenue by Type (2019-2024)
4.2.2 Global Androstenedione Revenue by Type (2025-2030)
4.2.3 Global Androstenedione Revenue Market Share by Type (2019-2030)
4.3 Global Androstenedione Price by Type (2019-2030)
5 Segment by Application
5.1 Global Androstenedione Sales by Application (2019-2030)
5.1.1 Global Androstenedione Sales by Application (2019-2024)
5.1.2 Global Androstenedione Sales by Application (2025-2030)
5.1.3 Global Androstenedione Sales Market Share by Application (2019-2030)
5.2 Global Androstenedione Revenue by Application (2019-2030)
5.2.1 Global Androstenedione Revenue by Application (2019-2024)
5.2.2 Global Androstenedione Revenue by Application (2025-2030)
5.2.3 Global Androstenedione Revenue Market Share by Application (2019-2030)
5.3 Global Androstenedione Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BIOVET
6.1.1 BIOVET Corporation Information
6.1.2 BIOVET Description and Business Overview
6.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BIOVET Androstenedione Product Portfolio
6.1.5 BIOVET Recent Developments/Updates
6.2 Indo Phyto Chemicals
6.2.1 Indo Phyto Chemicals Corporation Information
6.2.2 Indo Phyto Chemicals Description and Business Overview
6.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
6.2.5 Indo Phyto Chemicals Recent Developments/Updates
6.3 Sito Bio
6.3.1 Sito Bio Corporation Information
6.3.2 Sito Bio Description and Business Overview
6.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sito Bio Androstenedione Product Portfolio
6.3.5 Sito Bio Recent Developments/Updates
6.4 Goto Pharmaceutical
6.4.1 Goto Pharmaceutical Corporation Information
6.4.2 Goto Pharmaceutical Description and Business Overview
6.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
6.4.5 Goto Pharmaceutical Recent Developments/Updates
6.5 Tianjin King York
6.5.1 Tianjin King York Corporation Information
6.5.2 Tianjin King York Description and Business Overview
6.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tianjin King York Androstenedione Product Portfolio
6.5.5 Tianjin King York Recent Developments/Updates
6.6 Jiufu
6.6.1 Jiufu Corporation Information
6.6.2 Jiufu Description and Business Overview
6.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jiufu Androstenedione Product Portfolio
6.6.5 Jiufu Recent Developments/Updates
6.7 Yongning Pharma
6.6.1 Yongning Pharma Corporation Information
6.6.2 Yongning Pharma Description and Business Overview
6.6.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yongning Pharma Androstenedione Product Portfolio
6.7.5 Yongning Pharma Recent Developments/Updates
6.8 Jiangxi Hongyuan Pharmaceutical
6.8.1 Jiangxi Hongyuan Pharmaceutical Corporation Information
6.8.2 Jiangxi Hongyuan Pharmaceutical Description and Business Overview
6.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
6.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments/Updates
6.9 Kaizon
6.9.1 Kaizon Corporation Information
6.9.2 Kaizon Description and Business Overview
6.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kaizon Androstenedione Product Portfolio
6.9.5 Kaizon Recent Developments/Updates
6.10 Xi’an Gaoyuan Bio-Chem
6.10.1 Xi’an Gaoyuan Bio-Chem Corporation Information
6.10.2 Xi’an Gaoyuan Bio-Chem Description and Business Overview
6.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
6.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments/Updates
6.11 Dongyao Pharmaceutical
6.11.1 Dongyao Pharmaceutical Corporation Information
6.11.2 Dongyao Pharmaceutical Androstenedione Description and Business Overview
6.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
6.11.5 Dongyao Pharmaceutical Recent Developments/Updates
6.12 Huazhong Pharmaceutical
6.12.1 Huazhong Pharmaceutical Corporation Information
6.12.2 Huazhong Pharmaceutical Androstenedione Description and Business Overview
6.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
6.12.5 Huazhong Pharmaceutical Recent Developments/Updates
6.13 Darui
6.13.1 Darui Corporation Information
6.13.2 Darui Androstenedione Description and Business Overview
6.13.3 Darui Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Darui Androstenedione Product Portfolio
6.13.5 Darui Recent Developments/Updates
6.14 Danjiangkou Danao
6.14.1 Danjiangkou Danao Corporation Information
6.14.2 Danjiangkou Danao Androstenedione Description and Business Overview
6.14.3 Danjiangkou Danao Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Danjiangkou Danao Androstenedione Product Portfolio
6.14.5 Danjiangkou Danao Recent Developments/Updates
6.15 Dahua Pharmaceutical
6.15.1 Dahua Pharmaceutical Corporation Information
6.15.2 Dahua Pharmaceutical Androstenedione Description and Business Overview
6.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
6.15.5 Dahua Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androstenedione Industry Chain Analysis
7.2 Androstenedione Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androstenedione Production Mode & Process
7.4 Androstenedione Sales and Marketing
7.4.1 Androstenedione Sales Channels
7.4.2 Androstenedione Distributors
7.5 Androstenedione Customers
8 Androstenedione Market Dynamics
8.1 Androstenedione Industry Trends
8.2 Androstenedione Market Drivers
8.3 Androstenedione Market Challenges
8.4 Androstenedione Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research